🦊/People

Peter Emtage

InvestorFounder

Venture Partner at Versant Ventures · Founder & CEO at Santa Ana Bio · Executive at Cell Design Labs · Founder & CEO at Santa Ana

San Francisco Bay Area

Writes $100K – $5M checks · typically $1.5M

FoundedSanta AnaSanta Ana Bio

Find your path to Peter

81 people in our graph share verified history with Peter — schools, employers, funds. One of them is your warm intro.

Omar El-KhalafunlockedPeter: together at Versant Ventures (2023–2026)
×9Peter: together at Versant Ventures
×2Peter: together at Cell Design Labs

About

Peter Emtage joined Versant Ventures as an Entrepreneur-in-Residence in October 2020 and became a Venture Partner in April 2021. He previously led cell therapy research at Kite Pharma (a Gilead company) and held senior scientific roles at Cell Design Labs and MedImmune, with over 20 years of drug development experience in oncology, autoimmunity, infectious diseases and inflammation.

Founder & CEO at Santa Ana Bio

Intro paths

In turn, Peter can intro founders to Santa Ana Bio's investors below.

Co-founders at Santa Ana Bio

AR
Alexander RudenskyScientific Founder
RF
Richard FlavellScientific Founder
GLGraham Lord
Graham LordScientific Founder
ASAnsuman Satpathy
Ansuman SatpathyScientific Founder

Executive at Cell Design Labs

Intro paths

In turn, Peter can intro founders to Cell Design Labs's investors below.

Founder & CEO at Santa Ana

Intro paths

In turn, Peter can intro founders to Santa Ana's investors below.

Co-founders at Santa Ana

AR
Alexander RudenskyScientific Founder
RF
Richard FlavellScientific Founder
GLGraham Lord
Graham LordScientific Founder
ASAnsuman Satpathy
Ansuman SatpathyScientific Founder

Experience

  1. Santa Ana Bio, IncChief Executive Officercurrent2021 — present
  2. Versant VenturesVenture Partnercurrent2020 — present
  3. Kite PharmaGlobal Head of Cell Therapy Research2018 — 2020
  4. Cell Design LabsChief Scientific Officer2016 — 2018San Francisco, California

Skills & more

IND1Clinical Development99Biochemistry46Infectious Diseases23Cell Culture19GLP8Drug Discovery99GMP6Clinical Research10FDA13Antibodies13Vaccines6
+12 morePharmacologyBiologicsBiotherapeuticsAssay DevelopmentInflammationAutoimmunityOncologyBiomarker DiscoveryBiotechnologyBiopharmaceuticalsCancerCell

Languages English

From Peter's professional profile.

Investments

Per curated public sources.

Colleagues at Versant Ventures

Frequently asked questions

Who is Peter Emtage?
Peter Emtage joined Versant Ventures as an Entrepreneur-in-Residence in October 2020 and became a Venture Partner in April 2021. He previously led cell therapy research at Kite Pharma (a Gilead company) and held senior scientific roles at Cell Design Labs and MedImmune, with over 20 years of drug development experience in oncology, autoimmunity, infectious diseases and inflammation.
Where does Peter Emtage work?
Peter Emtage is Founder & CEO of Santa Ana and Venture Partner at Versant Ventures and Founder & CEO at Santa Ana Bio and Executive at Cell Design Labs.
What check size does Peter Emtage write?
Peter Emtage typically writes checks of $100K – $5M.
What companies did Peter Emtage found?
Peter Emtage founded Santa Ana, Santa Ana Bio.
What companies has Peter Emtage invested in?
Investments tracked here include Santa Ana Bio.

Founder mafias

Shared employers